½ÃÀ庸°í¼­
»óǰÄÚµå
1402213

¼¼°èÀÇ Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2030³â)

Global IV Hydration Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 172 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2022³â 34¾ï 6,000¸¸ ´Þ·¯¿¡¼­ 2030³â 65¾ï 2,000¸¸ ´Þ·¯¿¡ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2023-2030³âÀÇ Á¶»ç ±â°£ µ¿¾È 8.24%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤¸Æ³» ¼ö¾×¿ä¹ýÀº ¼ö¾×, ºñŸ¹Î, ¹Ì³×¶ö, ¾à¹°À» Á¤¸ÆÀ» ÅëÇØ °³ÀÎÀÇ Ç÷·ù¿¡ Á÷Á¢ Åõ¿©ÇÏ´Â ¹æ¹ýÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀº °æ±¸ ¼·Ãë¿¡ ºñÇØ ¿µ¾ç¼Ò¿Í ¼öºÐÀ» ´õ »¡¸® Èí¼öÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å»¼ö, ÇÇ·Î, µÎÅë°ú °°Àº Áõ»óÀ» ¿ÏÈ­ÇÏ°í ¿îµ¿ ´É·Â°ú ȸº¹À» µ½±â À§ÇØ »ç¿ëµÇ±âµµ ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

¿¹¹æÀû À£ºù°ú ¿¹¹æÀû °Ç°­ °ü¸®¿¡ ´ëÇÑ »çȸÀû °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ Á¦Ç°ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ºü¸¥ ¼öºÐ º¸Ãæ, ¿µ¾ç¼Ò ÁÖÀÔ, ÇÇ·Î ¹× ¼÷Ãë¿Í °°Àº Áõ»óÀ» ºü¸£°Ô ¿ÏÈ­ÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ¸Å·ÂÀûÀ̸ç, ¸¹Àº »ç¶÷µéÀÇ ¹Ù»Û ¶óÀÌÇÁ ½ºÅ¸ÀÏ¿¡ ºÎÇÕÇÕ´Ï´Ù. À¯¸íÀεé°ú ÀÎÇ÷ç¾ð¼­µéÀÌ ¼ö¾× ¿ä¹ýÀ» ¿ËÈ£Çϸ鼭 ±× Æ®·»µðÇÔÀº ´õ¿í ³ô¾ÆÁ³°í, ¼ÒºñÀÚµéÀÇ ¼±Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °Ý·ÄÇÑ ¿îµ¿ ÈÄ ¼º´É Çâ»ó°ú ºü¸¥ ȸº¹À» ¿øÇÏ´Â ¿îµ¿¼±¼öµéµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À£ºù ¼¾ÅÍ, ½ºÆÄ, Àü¹® Ŭ¸®´ÐÀÇ È®ÀåÀ¸·Î ¸ÂÃãÇü ¼ö¾× ¿ä¹ýÀÌ ´õ¿í Ä£¼÷ÇØÁö¸é¼­ ¼ÒºñÀڵ鿡°Ô ´õ °¡±îÀÌ ´Ù°¡¼­°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ¿É¼Ç, ¸ÂÃãÇü °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀνÄ, ¼öºÐ ¹× ¿µ¾ç º¸ÃæÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ÒºñÀÚÀÇ °ü½ÉÀ» ³ôÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Portre's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â Á¤¸Æ ¼öÈ­ ¿ä¹ý ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¤¸Æ ¼öÈ­ ¿ä¹ý »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤¸Æ ³» ¼ö¾× ¿ä¹ý ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ´ç»ç·Î ¿¬¶ô ºÎʵ右´Ï´Ù. ´ç»çÀÇ Á¶»ç ÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå Á¤¸Æ³» ¼ö¾×¿ä¹ý - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀå ºÐ¼® : ¼­ºñ½ºº°

  • ¼­ºñ½ºº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¼­ºñ½ºº° ºÐ¼®
  • ¸é¿ª ºÎ½ºÅÍ
  • ¿¡³ÊÁö ºÎ½ºÅÍ
  • ½ºÅ²Äɾî
  • ÆíµÎÅë
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀå ºÐ¼® : ¼ººÐº°

  • ¼ººÐº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¼ººÐº° ºÐ¼®
  • ¾à¿ë
  • ºñ¾à¿ë

Á¦7Àå ¼¼°èÀÇ Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾ ¿ëµµº° ºÐ¼®
  • º´¿ø ¹× Ŭ¸®´Ð
  • À£´Ï½º ¼¾ÅÍ ¹× ½ºÆÄ
  • ÀçÅà ÇコÄɾî
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå Á¤¸Æ³» ¼ö¾×¿ä¹ý ±â¾÷ÀÇ °æÀï ±¸µµ

  • Á¤¸Æ³» ¼ö¾×¿ä¹ý ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Core IV Therapy LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare
  • Baxter International Inc.
  • Drip Hydration
LSH 24.01.12

The global demand for IV Hydration Therapy Market is presumed to reach the market size of nearly USD 6.52 BN by 2030 from USD 3.46 BN in 2022 with a CAGR of 8.24% under the study period 2023 - 2030.

Intravenous (IV) hydration therapy entails the direct administration of fluids, vitamins, minerals, and medications into an individual's bloodstream via an intravenous line. This method allows for quicker absorption of nutrients and fluids compared to oral intake. It's often used to rehydrate individuals quickly, administering essential vitamins & minerals directly into the bloodstream, and sometimes to alleviate symptoms like dehydration, fatigue, and headaches, or to support athletic performance and recovery.

MARKET DYNAMICS

The societal shift toward proactive wellness and preventive healthcare has propelled its popularity. The appeal lies in its promise of rapid rehydration, nutrient infusion, and quick relief from conditions like fatigue and hangovers, aligning with the fast-paced lifestyles of many. Celebrities and influencers endorsing IV therapy have further amplified its trendiness, influencing consumer choices. Athletes seeking enhanced performance and faster recovery after intense workouts also contribute to the market's growth. Additionally, the expansion of wellness centers, spas, and specialized clinics offering tailored IV treatments has made them more accessible. Customization options, the perception of individualized health solutions, and increased awareness about the benefits of hydration and nutrient replenishment play significant roles in driving consumer interest.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of iv hydration therapy. The growth and trends of iv hydration therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the iv hydration therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others

By Component

  • Medicated
  • Non-Medicated

By End-Use

  • Hospitals & Clinics
  • Wellness Centers & Spas
  • Home Healthcare
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the IV Hydration Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the IV Hydration Therapy market include Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health, JW Life Science Corporation, Amanta Healthcare, Baxter International Inc., Drip Hydration. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IV HYDRATION THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Component
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IV HYDRATION THERAPY MARKET ANALYSIS BY SERVICE

  • 5.1 Overview by Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service
  • 5.4 Immune Boosters Historic and Forecast Sales by Regions
  • 5.5 Energy Boosters Historic and Forecast Sales by Regions
  • 5.6 Skin Care Historic and Forecast Sales by Regions
  • 5.7 Migraine Historic and Forecast Sales by Regions
  • 5.8 Others Historic and Forecast Sales by Regions

6 . GLOBAL IV HYDRATION THERAPY MARKET ANALYSIS BY COMPONENT

  • 6.1 Overview by Component
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Component
  • 6.4 Medicated Historic and Forecast Sales by Regions
  • 6.5 Non-medicated Historic and Forecast Sales by Regions

7 . GLOBAL IV HYDRATION THERAPY MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Hospitals & Clinics Historic and Forecast Sales by Regions
  • 7.5 Wellness Centers & Spas Historic and Forecast Sales by Regions
  • 7.6 Home Healthcare Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL IV HYDRATION THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IV HYDRATION THERAPY COMPANIES

  • 9.1. Iv Hydration Therapy Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF IV HYDRATION THERAPY INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Core IV Therapy LLC
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Cryojuvenate UK Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. B. Braun Medical Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Otsuka Pharmaceutical Co. Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. NexGen Health
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. JW Life Science Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Amanta Healthcare
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Baxter International Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Drip Hydration
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦